Chemotherapeutic intensity and survival differences in young patients with diffuse large B-cell lymphoma: a Swedish Lymphoma Registry study-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Chemotherapeutic intensity and survival differences in young patients with diffuse large B-cell lymphoma: a Swedish Lymphoma Registry study

Published:2016-10-28 Issue:4 Volume:175 Page:614-622
ISSN:0007-1048
Container-title:British Journal of Haematology
language:en
Short-container-title:Br J Haematol

Author:

Melén Christopher M.¹²,Enblad Gunilla³,Sonnevi Kristina¹²,Junlén Henna Riikka¹²,Smedby Karin E.⁴,Jerkeman Mats⁵,Wahlin Björn Engelbrekt¹²

Affiliation:

1. Division of Haematology; Department of Medicine; Huddinge Sweden

2. Karolinska Institutet, and Haematology Centre; Karolinska University Hospital; Stockholm Sweden

3. Department of Oncology; Uppsala University Hospital; Uppsala Sweden

4. Unit of Clinical Epidemiology, Department of Medicine; Solna Sweden

5. Department of Oncology; Lund University Hospital; Lund Sweden

Funder

Cancerfonden

Svenska Sällskapet för Medicinsk Forskning

Stockholms Läns Landsting

Publisher

Wiley

Subject

Hematology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/bjh.14399/fullpdf

Reference23 articles.

1. My treatment approach to patients with diffuse large B-cell lymphoma;Armitage;Mayo Clinic Proceedings,2012

2. CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma;Coiffier;New England Journal of Medicine,2002

3. Regression models and life-tables;Cox;Journal of the Royal Statistical Society: Series B,1972

4. Rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisolone in patients with newly diagnosed diffuse large B-cell non-Hodgkin lymphoma: a phase 3 comparison of dose intensification with 14-day versus 21-day cycles;Cunningham;Lancet,2011

5. R-CHOEP-14 improves overall survival in young high-risk patients with diffuse large B-cell lymphoma compared with R-CHOP-14. A population-based investigation from the Danish Lymphoma Group;Gang;Annals of Oncology,2012

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Regional differences in treatment and outcome for myeloma patients in Sweden: A population based Swedish myeloma register study;Cancer Reports;2022-03-03

2. Excellent survival after R‐Hyper‐CVAD in hospitalized patients with high‐risk large B‐cell lymphoma: The Karolinska experience;eJHaem;2021-09-28

3. High-dose methotrexate is effective for prevention of isolated CNS relapse in diffuse large B cell lymphoma;Blood Cancer Journal;2021-08

4. R-CHOEP14 in younger high-risk patients with large B cell lymphoma: an effective front-line regimen with cardiac toxicity: a real-life, single-center experience;Annals of Hematology;2020-11-20

5. Selective Release of Doxorubicin from Cucurbit[8]uril Stabilized Gold Supra‐Pyramid Host at pH of Small Intestine;Chemistry – A European Journal;2020-10-06

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3